Invitae

Invitae SG&A Expenses

Delisted

The Selling, General & Administrative Expenses of Invitae (NVTAQ) as of Nov 19, 2026 is 379.96 M USD. In the previous year, Selling, General & Administrative Expenses was 192.31 M USD — a change of 97.57% (higher).

SG&A Expenses

379.96 MUSD

YoY

97.57%

Last updated:

Selling, General & Administrative Expenses of Invitae is 2023 379.96 M USD. Selling, General & Administrative Expenses of Invitae was 2022 192.31 M USD. It decreases by 97.57% higher compared to the previous year.

The Invitae SG&A Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

SG&A Expenses
Date
SG&A Expenses
Jan 1, 2016
24.09 M USD
Jan 1, 2017
39.47 M USD
Jan 1, 2018
52.23 M USD
Jan 1, 2019
79.07 M USD
Jan 1, 2020
270.03 M USD
Jan 1, 2021
248.07 M USD
Jan 1, 2022
192.31 M USD
Jan 1, 2023
379.96 M USD
The Invitae SG&A Expenses history
YEARSG&A ExpensesYoY
379.96 MUSD+97.57%
192.31 MUSD-22.48%
248.07 MUSD-8.13%
270.03 MUSD+241.51%
79.07 MUSD+51.40%
52.23 MUSD+32.31%
39.47 MUSD+63.89%
24.09 MUSD+50.09%
16.05 MUSD+27.31%
12.61 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Invitae Stock analysis

What does Invitae do? Invitae Corp is a US-based company specialized in providing genetic tests for the diagnosis, treatment, and prevention of diseases. It was founded in 2010 and is headquartered in San Francisco, California. The company's goal is to lower the cost of genetic testing and increase accessibility for patients through automation and sample pooling methods. Invitae has received significant funding and has expanded its capital through multiple rounds of investments from venture capital firms, totaling nearly half a billion dollars. Its business model focuses on offering genetic tests to a wide range of patient groups, streamlining the testing processes through automation and software optimization. Invitae serves consumers directly, as well as medical professionals, hospitals, health centers, laboratories, and health insurance companies. The company aims to improve disease diagnosis and early detection while promoting long-term patient health. Invitae has broadened its capabilities through strategic acquisitions and partnerships, consolidating genetic data on a single platform. It offers a diverse portfolio of genetic tests for the diagnosis, treatment, and prevention of various diseases, including cancer predisposition, cardiovascular diseases, rare inherited diseases, neurological disorders, and medical genomics. The company also provides genetic counseling and family-oriented diagnosis services, along with an online platform facilitating interactive communication between doctors and patients, enabling the sharing and presentation of genetic information and test results. Invitae is an innovative company that has established itself as a market leader in genetic testing, offering a wide range of products and services facilitated by advanced technologies and data storage solutions. The recent acquisitions and partnerships have expanded Invitae's portfolio, improved its technology platform, and strengthened its position as a provider of high-quality healthcare services, enabling well-informed decision-making for patients and medical professionals. Invitae is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Invitae stock

Selling, General & Administrative Expenses of Invitae is 379.96 M USD in 2023.

Selling, General & Administrative Expenses of Invitae changed from 192.31 M USD to 379.96 M USD, representing a 97.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Selling, General & Administrative Expenses Invitae since 2006 – with annual values, charts, and detailed analysis.

SG&A expenses include all non-production costs such as salaries, marketing, rent, and administrative overhead. They are a key component of operating expenses.

Selling, General & Administrative Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Selling, General & Administrative Expenses's Invitae historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Invitae

All Key Metrics — Invitae